Catalyst Wire Dossier Catalyst Wire Dossier

Eprosartan Mesylate

eprosartan mesylate · Abbott Laboratories
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eprosartan Mesylate, covering 2014-05-26 to 2014-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension [Phase 3]

See pricing